Emmessar Biotech Nutrition Ltd vs Resonance Specialities Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 24, 2026

Key Highlights

The Latest Trading Price of Emmessar Biotech & Nutrition Ltd is ₹ 23.22 as of 24 Mar 15:18 . The P/E Ratio of Emmessar Biotech & Nutrition Ltd changed from 5.1 on March 2021 to 48.2 on March 2025 . This represents a CAGR of 56.71% over 5 yearsThe P/E Ratio of Resonance Specialities Ltd changed from 13.8 on March 2021 to 11.8 on March 2025 . This represents a CAGR of -3.08% over 5 years The Market Cap of Emmessar Biotech & Nutrition Ltd changed from ₹ 7.35 crore on March 2021 to ₹ 15.2 crore on March 2025 . This represents a CAGR of 15.64% over 5 yearsThe Market Cap of Resonance Specialities Ltd changed from ₹ 144.71 crore on March 2021 to ₹ 77.39 crore on March 2025 . This represents a CAGR of -11.77% over 5 years The revenue of Emmessar Biotech & Nutrition Ltd for the Dec '25 is ₹ 0.58 crore as compare to the Sep '25 revenue of ₹ 0.63 crore. This represent the decline of -7.94% The revenue of Resonance Specialities Ltd for the Dec '25 is ₹ 23.29 crore as compare to the Sep '25 revenue of ₹ 21.89 crore. This represent the growth of 6.4% The ebitda of Emmessar Biotech & Nutrition Ltd for the Dec '25 is ₹ 0.15 crore as compare to the Sep '25 ebitda of ₹ 0.17 crore. This represent the decline of -11.76% The ebitda of Resonance Specialities Ltd for the Dec '25 is ₹ 3.77 crore as compare to the Sep '25 ebitda of ₹ 2.72 crore. This represent the growth of 38.6% The net profit of Emmessar Biotech & Nutrition Ltd changed from ₹ 0.09 crore to ₹ 0.12 crore over 7 quarters. This represents a CAGR of 17.87% The net profit of Resonance Specialities Ltd changed from ₹ 0.59 crore to ₹ 2.51 crore over 7 quarters. This represents a CAGR of 128.73% The Dividend Payout of Emmessar Biotech & Nutrition Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Resonance Specialities Ltd changed from 10.97 % on March 2021 to 17.56 % on March 2025 . This represents a CAGR of 9.87% over 5 years .

About Emmessar Biotech & Nutrition Ltd

Emmessar Biotech & Nutrition Limited (EBNL), originally established on 17th March 1992 as Emmessar Chemical Industries Ltd (ECIL) started its operations in manufacturing Super Specialty Fine Chemicals.
The Company has so far, succeeded in developing many Specialty Fine Chemicals.
ECIL gained official recognition for its R&D from DSIR, Ministry of Science & Technology, Government of India, New-Delhi in early 1996.
To better represent its new core activity, a change in the Company name from Emmessar Chemical Industries Ltd (ECIL) to Emmessar Biotech & Nutrition Ltd (EBNL) on April 7, 2000, was made essential. On realizing that some of the specialty chemicals developed & exported to USA & Europe was being used in producing healthcare formulations, the Company plunged into a new venture in the Healthcare business, where phenomenal growth in the coming decades was anticipated.

About Resonance Specialities Ltd

Resonance Specialities Limited (Formerly known Armour Polymers Limited) was incorporated in June, 1989 as a Private Limited Company in Maharashtra.
The Company thereafter got converted into a Public Limited Company in March, 1990.
The Company is manufacturing and marketing of Pyridine and Pyridine derivatives, Picoline, Collidines, Cynopyridine and some bulk drugs.
Bulks drugs and nutritional products are toll converted.
In view of multi products manufacturing and frictional distillation in batches, overall average product cycle is around 2 to 4 months from the procurement till the disposal. The Company's plant is located in the Tarapur Industrial Zone near Mumbai , India.

FAQs for the comparison of Emmessar Biotech & Nutrition Ltd and Resonance Specialities Ltd

Which company has a larger market capitalization, Emmessar Biotech & Nutrition Ltd or Resonance Specialities Ltd?

Market cap of Emmessar Biotech & Nutrition Ltd is 11 Cr while Market cap of Resonance Specialities Ltd is 101 Cr

What are the key factors driving the stock performance of Emmessar Biotech & Nutrition Ltd and Resonance Specialities Ltd?

The stock performance of Emmessar Biotech & Nutrition Ltd and Resonance Specialities Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Emmessar Biotech & Nutrition Ltd and Resonance Specialities Ltd?

As of March 24, 2026, the Emmessar Biotech & Nutrition Ltd stock price is INR ₹23.02. On the other hand, Resonance Specialities Ltd stock price is INR ₹87.67.

How do dividend payouts of Emmessar Biotech & Nutrition Ltd and Resonance Specialities Ltd compare?

To compare the dividend payouts of Emmessar Biotech & Nutrition Ltd and Resonance Specialities Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.